Searchable abstracts of presentations at key conferences in endocrinology

ea0035p855 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

The effects of octreotide acetate long-acting repeatable on mean platelet volume in acromegaly: octreotidelar may have a detrimental effect on MPV, a new indicator of atherosclerosis

Durmaz Senay Arikan , Carlioglu Ayse , Ayhan Emin , Macunluoglu Beyza

Introduction and objective: Cardiovascular mortality is high in acromegaly. Our aim in this study was to determine the levels of the new cardiovascular marker in active acromegaly patients, the mean platelet volume (MPV) values before and after octreotide acetate long-acting repeatable treatment.Material and methods: Thirty-six patients with active acromegaly who presented at the Endocrinology Department (mean age 46.0±14.0 years and mean BMI: 30.4&...

ea0090ep1107 | Late Breaking | ECE2023

HbA1c and Lipid Profile Indices: Useful for cardiovascular risk prediction in non-diabetics?

Cicek Beyza , Okuturlar Yildiz , Cem Deniz Orhan , Okuturlar Ozgur , Celik Ozlem , Serteser Mustafa , Şahin Sevgi

Aims: Glycosylated hemoglobin (HbA1c) is a marker which demonstrates 3-month average level of blood glucose level. In individuals with high blood sugar level for a long time is associated with increased risk of cardiovascular disease (CVD). There is a need for simple and cost-effective markers to determine the risk of CVD in primary health care settings. In this study, we aimed to investigate the value of HbA1c for predicting cardiovascular risk in healthy non-diabetic individ...